Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Mol Psychiatry

Retrieve available abstracts of 109 articles:
HTML format

Single Articles

    November 2021
  1. ALKELAI A, Greenbaum L, Docherty AR, Shabalin AA, et al
    The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders.
    Mol Psychiatry. 2021 Nov 19. pii: 10.1038/s41380-021-01383.
    PubMed     Abstract available

  2. ZHANG R, Sjolander A, Ploner A, Lu D, et al
    Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.
    Mol Psychiatry. 2021 Nov 19. pii: 10.1038/s41380-021-01387.
    PubMed     Abstract available

  3. NOTARAS M, Lodhi A, Dundar F, Collier P, et al
    Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids.
    Mol Psychiatry. 2021 Nov 17. pii: 10.1038/s41380-021-01316.
    PubMed     Abstract available

  4. EISENBERG DP, Kohn PD, Hegarty CE, Smith NR, et al
    Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia.
    Mol Psychiatry. 2021 Nov 17. pii: 10.1038/s41380-021-01337.
    PubMed     Abstract available

  5. PLAVEN-SIGRAY P, Ikonen Victorsson P, Santillo A, Matheson GJ, et al
    Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.
    Mol Psychiatry. 2021 Nov 10. pii: 10.1038/s41380-021-01349.
    PubMed     Abstract available

  6. CUENOD M, Steullet P, Cabungcal JH, Dwir D, et al
    Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.
    Mol Psychiatry. 2021 Nov 10. pii: 10.1038/s41380-021-01374.
    PubMed     Abstract available

  7. ZHOU X
    Over-representation of potential SP4 target genes within schizophrenia-risk genes.
    Mol Psychiatry. 2021 Nov 8. pii: 10.1038/s41380-021-01376.
    PubMed     Abstract available

  8. SELLGREN CM, Imbeault S, Larsson MK, Oliveros A, et al
    Correction: GRK3 deficiency elicits brain immune activation and psychosis.
    Mol Psychiatry. 2021 Nov 8. pii: 10.1038/s41380-021-01371.

  9. CAMPEAU A, Mills RH, Stevens T, Rossitto LA, et al
    Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia.
    Mol Psychiatry. 2021 Nov 5. pii: 10.1038/s41380-021-01339.
    PubMed     Abstract available

  10. GAO Y, Fan Y, Yang Z, Ma Q, et al
    Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia.
    Mol Psychiatry. 2021 Nov 2. pii: 10.1038/s41380-021-01362.
    PubMed     Abstract available

    October 2021
  11. CHAN SY, Brady RO, Lewandowski KE, Higgins A, et al
    Dynamic and progressive changes in thalamic functional connectivity over the first five years of psychosis.
    Mol Psychiatry. 2021 Oct 25. pii: 10.1038/s41380-021-01319.
    PubMed     Abstract available

  12. KHADIMALLAH I, Jenni R, Cabungcal JH, Cleusix M, et al
    Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
    Mol Psychiatry. 2021 Oct 22. pii: 10.1038/s41380-021-01313.
    PubMed     Abstract available

  13. WOLF DH, Zheng D, Kohler C, Turetsky BI, et al
    Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia.
    Mol Psychiatry. 2021 Oct 20. pii: 10.1038/s41380-021-01320.
    PubMed     Abstract available

  14. YANG K, Longo L, Narita Z, Cascella N, et al
    A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance.
    Mol Psychiatry. 2021 Oct 12. pii: 10.1038/s41380-021-01331.
    PubMed     Abstract available

    September 2021
  15. LUO C, Pi X, Hu N, Wang X, et al
    Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function.
    Mol Psychiatry. 2021 Sep 29. pii: 10.1038/s41380-021-01308.
    PubMed     Abstract available

  16. NAKAHARA T, Tsugawa S, Noda Y, Ueno F, et al
    Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of (1)H-magnetic resonance spectroscopy studies.
    Mol Psychiatry. 2021 Sep 28. pii: 10.1038/s41380-021-01297.
    PubMed     Abstract available

    August 2021
  17. STAUFFER EM, Bethlehem RAI, Warrier V, Murray GK, et al
    Grey and white matter microstructure is associated with polygenic risk for schizophrenia.
    Mol Psychiatry. 2021 Aug 30. pii: 10.1038/s41380-021-01260.
    PubMed     Abstract available

  18. LI Y, Li S, Liu J, Huo Y, et al
    The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia.
    Mol Psychiatry. 2021 Aug 10. pii: 10.1038/s41380-021-01261.

  19. RAUBER S, Heming M, Repple J, Ruland T, et al
    Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses.
    Mol Psychiatry. 2021 Aug 6. pii: 10.1038/s41380-021-01244.
    PubMed     Abstract available

    July 2021
  20. LIU Z, Palaniyappan L, Wu X, Zhang K, et al
    Resolving heterogeneity in schizophrenia through a novel systems approach to brain structure: individualized structural covariance network analysis.
    Mol Psychiatry. 2021 Jul 28. pii: 10.1038/s41380-021-01229.
    PubMed     Abstract available

  21. MURPHY CE, Weickert CS
    A new suspect in the unsolved case of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2021 Jul 20. pii: 10.1038/s41380-021-01225.

  22. WU X, Shukla R, Alganem K, Zhang X, et al
    Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity.
    Mol Psychiatry. 2021 Jul 16. pii: 10.1038/s41380-021-01205.
    PubMed     Abstract available

  23. HEURICH M, Focking M, Mongan D, Cagney G, et al
    Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.
    Mol Psychiatry. 2021 Jul 5. pii: 10.1038/s41380-021-01197.
    PubMed     Abstract available

  24. SHA Z, Schijven D, Francks C
    Patterns of brain asymmetry associated with polygenic risks for autism and schizophrenia implicate language and executive functions but not brain masculinization.
    Mol Psychiatry. 2021 Jul 1. pii: 10.1038/s41380-021-01204.
    PubMed     Abstract available

    June 2021
  25. ZHU X, Cabungcal JH, Cuenod M, Uliana DL, et al
    Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine.
    Mol Psychiatry. 2021 Jun 30. pii: 10.1038/s41380-021-01198.
    PubMed     Abstract available

  26. GUAN F, Ni T, Zhu W, Williams LK, et al
    Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.
    Mol Psychiatry. 2021 Jun 30. pii: 10.1038/s41380-021-01201.
    PubMed     Abstract available

  27. GAO WJ, Yang SS, Mack NR, Chamberlin LA, et al
    Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction.
    Mol Psychiatry. 2021 Jun 23. pii: 10.1038/s41380-021-01196.
    PubMed     Abstract available

  28. ROGDAKI M, Devroye C, Ciampoli M, Veronese M, et al
    Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Mol Psychiatry. 2021 Jun 22. pii: 10.1038/s41380-021-01192.

  29. RADHAKRISHNAN R, Skosnik PD, Ranganathan M, Naganawa M, et al
    In vivo evidence of lower synaptic vesicle density in schizophrenia.
    Mol Psychiatry. 2021 Jun 16. pii: 10.1038/s41380-021-01184.
    PubMed     Abstract available

  30. DEMICHELE-SWEET MAA, Klei L, Creese B, Harwood JC, et al
    Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
    Mol Psychiatry. 2021 Jun 10. pii: 10.1038/s41380-021-01152.
    PubMed     Abstract available

  31. TIGARET CM, Lin TE, Morrell ER, Sykes L, et al
    Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c.
    Mol Psychiatry. 2021;26:1748-1760.
    PubMed     Abstract available

  32. BYRNE EM, Zhu Z, Qi T, Skene NG, et al
    Conditional GWAS analysis to identify disorder-specific SNPs for psychiatric disorders.
    Mol Psychiatry. 2021;26:2070-2081.
    PubMed     Abstract available

  33. PEREZ JM, Berto S, Gleason K, Ghose S, et al
    Hippocampal subfield transcriptome analysis in schizophrenia psychosis.
    Mol Psychiatry. 2021;26:2577-2589.
    PubMed     Abstract available

  34. CAO H, Zhou H, Cannon TD
    Functional connectome-wide associations of schizophrenia polygenic risk.
    Mol Psychiatry. 2021;26:2553-2561.
    PubMed     Abstract available

  35. MA L, Shcherbina A, Chetty S
    Variations and expression features of CYP2D6 contribute to schizophrenia risk.
    Mol Psychiatry. 2021;26:2605-2615.
    PubMed     Abstract available

    May 2021
  36. WEISSLEDER C, North HF, Bitar M, Fullerton JM, et al
    Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia.
    Mol Psychiatry. 2021 May 31. pii: 10.1038/s41380-021-01149.
    PubMed     Abstract available

  37. DI BIASE MA, Cetin-Karayumak S, Lyall AE, Zalesky A, et al
    White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.
    Mol Psychiatry. 2021 May 24. pii: 10.1038/s41380-021-01128.
    PubMed     Abstract available

  38. CHADHA R, Alganem K, Mccullumsmith RE, Meador-Woodruff JH, et al
    mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
    Mol Psychiatry. 2021 May 14. pii: 10.1038/s41380-021-01135.
    PubMed     Abstract available

  39. KARIMI B, Silwal P, Booth S, Padmanabhan N, et al
    Schizophrenia-associated LRRTM1 regulates cognitive behavior through controlling synaptic function in the mediodorsal thalamus.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01146.
    PubMed     Abstract available

  40. ROGDAKI M, Devroye C, Ciampoli M, Veronese M, et al
    Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01108.
    PubMed     Abstract available

  41. SELLGREN CM, Imbeault S, Larsson MK, Oliveros A, et al
    GRK3 deficiency elicits brain immune activation and psychosis.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01106.
    PubMed     Abstract available

    April 2021
  42. LI Y, Ma C, Li W, Yang Y, et al
    A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.
    Mol Psychiatry. 2021 Apr 30. pii: 10.1038/s41380-021-01125.
    PubMed     Abstract available

  43. SHEN M, Guo Y, Dong Q, Gao Y, et al
    FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors.
    Mol Psychiatry. 2021 Apr 16. pii: 10.1038/s41380-021-01096.
    PubMed     Abstract available

  44. DRUART M, Nosten-Bertrand M, Poll S, Crux S, et al
    Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes.
    Mol Psychiatry. 2021 Apr 9. pii: 10.1038/s41380-021-01081.
    PubMed     Abstract available

  45. ANDLAUER TFM, Guzman-Parra J, Streit F, Strohmaier J, et al
    Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders.
    Mol Psychiatry. 2021;26:1286-1298.
    PubMed     Abstract available

  46. LEGGIO GM, Torrisi SA, Mastrogiacomo R, Mauro D, et al
    The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.
    Mol Psychiatry. 2021;26:1272-1285.
    PubMed     Abstract available

    March 2021
  47. ZHANG CY, Xiao X, Zhang Z, Hu Z, et al
    An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data.
    Mol Psychiatry. 2021 Mar 8. pii: 10.1038/s41380-021-01037.
    PubMed     Abstract available

  48. TAKAHASHI Y, Maynard KR, Tippani M, Jaffe AE, et al
    Single molecule in situ hybridization reveals distinct localizations of schizophrenia risk-related transcripts SNX19 and AS3MT in human brain.
    Mol Psychiatry. 2021 Mar 1. pii: 10.1038/s41380-021-01046.
    PubMed     Abstract available

  49. SINHA V, Ukkola-Vuoti L, Ortega-Alonso A, Torniainen-Holm M, et al
    Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population.
    Mol Psychiatry. 2021;26:816-824.
    PubMed     Abstract available

    February 2021
  50. GRUBISHA MJ, Sun X, MacDonald ML, Garver M, et al
    MAP2 is differentially phosphorylated in schizophrenia, altering its function.
    Mol Psychiatry. 2021 Feb 1. pii: 10.1038/s41380-021-01034.
    PubMed     Abstract available

  51. RATHJE M, Waxman H, Benoit M, Tammineni P, et al
    Genetic variants in the bipolar disorder risk locus SYNE1 that affect CPG2 expression and protein function.
    Mol Psychiatry. 2021;26:508-523.
    PubMed     Abstract available

    January 2021
  52. CUI X, McGrath JJ, Burne THJ, Eyles DW, et al
    Vitamin D and schizophrenia: 20 years on.
    Mol Psychiatry. 2021 Jan 26. pii: 10.1038/s41380-021-01025.
    PubMed     Abstract available

  53. RATANATHARATHORN A, Koenen KC, Chibnik LB, Weisskopf MG, et al
    Polygenic risk for autism, attention-deficit hyperactivity disorder, schizophrenia, major depressive disorder, and neuroticism is associated with the experience of childhood abuse.
    Mol Psychiatry. 2021 Jan 22. pii: 10.1038/s41380-020-00996.
    PubMed     Abstract available

  54. SEITZ-HOLLAND J, Cetin-Karayumak S, Wojcik JD, Lyall A, et al
    Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.
    Mol Psychiatry. 2021 Jan 22. pii: 10.1038/s41380-021-01018.
    PubMed     Abstract available

  55. HUANG Y, Jiang H, Zheng Q, Fok AHK, et al
    Environmental enrichment or selective activation of parvalbumin-expressing interneurons ameliorates synaptic and behavioral deficits in animal models with schizophrenia-like behaviors during adolescence.
    Mol Psychiatry. 2021 Jan 20. pii: 10.1038/s41380-020-01005.
    PubMed     Abstract available

  56. WANG D, Peng X, Pelletier-Baldelli A, Orlov N, et al
    Altered temporal, but intact spatial, features of transient network dynamics in psychosis.
    Mol Psychiatry. 2021 Jan 18. pii: 10.1038/s41380-020-00983.
    PubMed     Abstract available

  57. TARANTINO N, Leboyer M, Bouleau A, Hamdani N, et al
    Natural killer cells in first-episode psychosis: an innate immune signature?
    Mol Psychiatry. 2021 Jan 17. pii: 10.1038/s41380-020-01008.
    PubMed     Abstract available

  58. ROESKE MJ, McHugo M, Vandekar S, Blackford JU, et al
    Incomplete hippocampal inversion in schizophrenia: prevalence, severity, and impact on hippocampal structure.
    Mol Psychiatry. 2021 Jan 12. pii: 10.1038/s41380-020-01010.
    PubMed     Abstract available

  59. ROOSTERMAN D, Cottrell GS
    The two-cell model of glucose metabolism: a hypothesis of schizophrenia.
    Mol Psychiatry. 2021 Jan 5. pii: 10.1038/s41380-020-00980.
    PubMed     Abstract available

  60. LI M, Li Y, Qin H, Tubbs JD, et al
    Correction: Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population.
    Mol Psychiatry. 2021 Jan 4. pii: 10.1038/s41380-020-01013.

  61. NORTHOFF G, Hirjak D, Wolf RC, Magioncalda P, et al
    All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders.
    Mol Psychiatry. 2021;26:92-102.
    PubMed     Abstract available

    December 2020
  62. HUANG Y, Huang J, Zhou QX, Yang CX, et al
    ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors.
    Mol Psychiatry. 2020 Dec 10. pii: 10.1038/s41380-020-00972.
    PubMed     Abstract available

  63. LI M, Li Y, Qin H, Tubbs JD, et al
    Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population.
    Mol Psychiatry. 2020 Dec 5. pii: 10.1038/s41380-020-00968.
    PubMed     Abstract available

  64. LICINIO J, Wong ML
    Advances in schizophrenia research: glycobiology, white matter abnormalities, and their interactions.
    Mol Psychiatry. 2020;25:3116-3118.

    November 2020
  65. MARX W, McGuinness AJ, Rocks T, Ruusunen A, et al
    The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
    Mol Psychiatry. 2020 Nov 23. pii: 10.1038/s41380-020-00951.
    PubMed     Abstract available

  66. TROMP A, Mowry B, Giacomotto J
    Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.
    Mol Psychiatry. 2020 Nov 15. pii: 10.1038/s41380-020-00944.
    PubMed     Abstract available

  67. GIRGIS RR, Slifstein M, Brucato G, Kegeles LS, et al
    Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [(11)C]-(+)-PHNO PET with methylphenidate challenge study.
    Mol Psychiatry. 2020 Nov 5. pii: 10.1038/s41380-020-00934.
    PubMed     Abstract available

  68. ZIMMERMAN AJ, Hafez AK, Amoah SK, Rodriguez BA, et al
    A psychiatric disease-related circular RNA controls synaptic gene expression and cognition.
    Mol Psychiatry. 2020;25:2712-2727.
    PubMed     Abstract available

  69. MANCINI V, Sandini C, Padula MC, Zoller D, et al
    Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
    Mol Psychiatry. 2020;25:2844-2859.
    PubMed     Abstract available

  70. VAN DER MEER D, Rokicki J, Kaufmann T, Cordova-Palomera A, et al
    Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes.
    Mol Psychiatry. 2020;25:3053-3065.
    PubMed     Abstract available

    October 2020
  71. COUGHLIN JM, Yang K, Marsman A, Pradhan S, et al
    A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia.
    Mol Psychiatry. 2020 Oct 19. pii: 10.1038/s41380-020-00901.
    PubMed     Abstract available

  72. POLLAK TA, Kempton MJ, Iyegbe C, Vincent A, et al
    Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
    Mol Psychiatry. 2020 Oct 19. pii: 10.1038/s41380-020-00899.
    PubMed     Abstract available

  73. LIZANO P, Lutz O, Xu Y, Rubin LH, et al
    Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis.
    Mol Psychiatry. 2020 Oct 15. pii: 10.1038/s41380-020-00914.
    PubMed     Abstract available

  74. SCHWARZ E, Alnaes D, Andreassen OA, Cao H, et al
    Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap.
    Mol Psychiatry. 2020 Oct 15. pii: 10.1038/s41380-020-00915.

  75. HAARSMA J, Fletcher PC, Griffin JD, Taverne HJ, et al
    Correction: Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.
    Mol Psychiatry. 2020 Oct 14. pii: 10.1038/s41380-020-00919.
    PubMed     Abstract available

  76. LAGO SG, Tomasik J, van Rees GF, Ramsey JM, et al
    Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.
    Mol Psychiatry. 2020;25:2355-2372.
    PubMed     Abstract available

    September 2020
  77. LV J, Di Biase M, Cash RFH, Cocchi L, et al
    Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort.
    Mol Psychiatry. 2020 Sep 22. pii: 10.1038/s41380-020-00882.
    PubMed     Abstract available

  78. KIM S, Shin SH, Santangelo B, Veronese M, et al
    Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [(18)F]DOPA and [(11)C]raclopride PET study in first-episode psychosis.
    Mol Psychiatry. 2020 Sep 14. pii: 10.1038/s41380-020-00879.
    PubMed     Abstract available

  79. DING C, Zhang C, Kopp R, Kuney L, et al
    Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia.
    Mol Psychiatry. 2020 Sep 14. pii: 10.1038/s41380-020-00877.
    PubMed     Abstract available

    August 2020
  80. SAWADA T, Chater TE, Sasagawa Y, Yoshimura M, et al
    Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids.
    Mol Psychiatry. 2020 Aug 7. pii: 10.1038/s41380-020-0844.
    PubMed     Abstract available

  81. THAPAR A, Riglin L
    The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?
    Mol Psychiatry. 2020;25:1631-1639.
    PubMed     Abstract available

  82. ROGDAKI M, Gudbrandsen M, McCutcheon RA, Blackmore CE, et al
    Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.
    Mol Psychiatry. 2020;25:1704-1717.
    PubMed     Abstract available

    July 2020
  83. ROESKE MJ, Konradi C, Heckers S, Lewis AS, et al
    Hippocampal volume and hippocampal neuron density, number and size in schizophrenia: a systematic review and meta-analysis of postmortem studies.
    Mol Psychiatry. 2020 Jul 28. pii: 10.1038/s41380-020-0853.
    PubMed     Abstract available

  84. THYGESEN JH, Presman A, Harju-Seppanen J, Irizar H, et al
    Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study.
    Mol Psychiatry. 2020 Jul 27. pii: 10.1038/s41380-020-0820.
    PubMed     Abstract available

  85. MCNALLY JM, Aguilar DD, Katsuki F, Radzik LK, et al
    Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia.
    Mol Psychiatry. 2020 Jul 20. pii: 10.1038/s41380-020-0840.
    PubMed     Abstract available

  86. FOURNIER M, Scolamiero M, Gholam-Rezaee MM, Cleusix M, et al
    Topology predicts long-term functional outcome in early psychosis.
    Mol Psychiatry. 2020 Jul 6. pii: 10.1038/s41380-020-0826.
    PubMed     Abstract available

    June 2020
  87. CONEN S, Gregory CJ, Hinz R, Smallman R, et al
    Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis.
    Mol Psychiatry. 2020 Jun 30. pii: 10.1038/s41380-020-0829.
    PubMed     Abstract available

  88. HAARSMA J, Fletcher PC, Griffin JD, Taverne HJ, et al
    Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.
    Mol Psychiatry. 2020 Jun 24. pii: 10.1038/s41380-020-0803.
    PubMed     Abstract available

  89. REGEN F, Cosma NC, Otto LR, Clemens V, et al
    Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophrenia.
    Mol Psychiatry. 2020 Jun 2. pii: 10.1038/s41380-020-0791.
    PubMed     Abstract available

    May 2020
  90. PRICE AJ, Jaffe AE, Weinberger DR
    Cortical cellular diversity and development in schizophrenia.
    Mol Psychiatry. 2020 May 13. pii: 10.1038/s41380-020-0775.
    PubMed     Abstract available

  91. WILLIAMS SE, Mealer RG, Scolnick EM, Smoller JW, et al
    Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies.
    Mol Psychiatry. 2020 May 13. pii: 10.1038/s41380-020-0761.
    PubMed     Abstract available

  92. KRAGULJAC NV, Anthony T, Morgan CJ, Jindal RD, et al
    White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naive first-episode psychosis patients.
    Mol Psychiatry. 2020 May 12. pii: 10.1038/s41380-020-0765.
    PubMed     Abstract available

  93. KOKKINOU M, Irvine EE, Bonsall DR, Natesan S, et al
    Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
    Mol Psychiatry. 2020 May 7. pii: 10.1038/s41380-020-0740.
    PubMed     Abstract available

  94. ZHANG R, Larsen JT, Kuja-Halkola R, Thornton L, et al
    Familial co-aggregation of schizophrenia and eating disorders in Sweden and Denmark.
    Mol Psychiatry. 2020 May 7. pii: 10.1038/s41380-020-0749.
    PubMed     Abstract available

  95. MEALER RG, Williams SE, Daly MJ, Scolnick EM, et al
    Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research.
    Mol Psychiatry. 2020 May 6. pii: 10.1038/s41380-020-0753.
    PubMed     Abstract available

    April 2020
  96. MARQUES TR, Ashok AH, Angelescu I, Borgan F, et al
    GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513.
    Mol Psychiatry. 2020 Apr 15. pii: 10.1038/s41380-020-0711.
    PubMed     Abstract available

  97. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    Differences in fractional anisotropy between the patients with schizophrenia and healthy comparison subjects.
    Mol Psychiatry. 2020;25:697-698.

    Advances in schizophrenia research: first special issue, 2020.
    Mol Psychiatry. 2020;25:699-700.

  99. PASSOS IC, Mwangi B
    Machine learning-guided intervention trials to predict treatment response at an individual patient level: an important second step following randomized clinical trials.
    Mol Psychiatry. 2020;25:701-702.

  100. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals.
    Mol Psychiatry. 2020;25:883-895.
    PubMed     Abstract available

    March 2020
  101. DWIR D, Giangreco B, Xin L, Tenenbaum L, et al
    Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
    Mol Psychiatry. 2020 Mar 26. pii: 10.1038/s41380-020-0716.
    PubMed     Abstract available

  102. GORDOVEZ FJA, McMahon FJ
    The genetics of bipolar disorder.
    Mol Psychiatry. 2020;25:544-559.
    PubMed     Abstract available

  103. SONDERBY IE, Gustafsson O, Doan NT, Hibar DP, et al
    Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.
    Mol Psychiatry. 2020;25:584-602.
    PubMed     Abstract available

    February 2020
  104. CHASE HW, Boudewyn MA, Carter CS, Phillips ML, et al
    Transcranial direct current stimulation: a roadmap for research, from mechanism of action to clinical implementation.
    Mol Psychiatry. 2020;25:397-407.
    PubMed     Abstract available

    January 2020
  105. YANG Z, Zhou D, Li H, Cai X, et al
    The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.
    Mol Psychiatry. 2020;25:48-66.
    PubMed     Abstract available

  106. BARESIC A, Nash AJ, Dahoun T, Howes O, et al
    Understanding the genetics of neuropsychiatric disorders: the potential role of genomic regulatory blocks.
    Mol Psychiatry. 2020;25:6-18.
    PubMed     Abstract available

  107. REN M, Hu Z, Chen Q, Jaffe A, et al
    KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits.
    Mol Psychiatry. 2020;25:206-229.
    PubMed     Abstract available

    The development of Kraepelin's mature diagnostic concept of hebephrenia: a close reading of relevant texts of Hecker, Daraszkiewicz, and Kraepelin.
    Mol Psychiatry. 2020;25:180-193.
    PubMed     Abstract available

  109. KANO SI, Hodgkinson CA, Jones-Brando L, Eastwood S, et al
    Host-parasite interaction associated with major mental illness.
    Mol Psychiatry. 2020;25:194-205.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.